Health Kick Podcast: Can listed Aussie drug makers survive COVID-19?
Health & Biotech
Link copied to
Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast.
In this episode Tim chats with Dr James Campbell, CEO of Patrys (ASX:PAB).
Patrys is a Melbourne-based company focused on the commercialisation of novel antibody therapeutics for oncology.
The company is initially targeting underserved oncology indications, such as glioblastoma and metastatic triple-negative breast cancer, with the potential for expanding to other indications.
Patrys recently announced new pre-clinical data for its lead candidate, explaining PAT-DX1’s ability to cross the blood-brain barrier.
So tune in below to hear the pair discuss drug developers in the current crisis and the company’s latest developments.
Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!